Pharmmies

Company Overview

Snapshot

Founded in January 2023 by Roy Birman, Pharmmies operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the research and development of its innovative pharmaceutical gummies.

Business overview

Pharmmies specializes in the development of pharmaceutical gummies that incorporate precise dosages of Active Pharmaceutical Ingredients. The company's core technology involves infusing these active compounds into gummy formulations, addressing the need for accurate and palatable drug delivery. Pharmmies primarily serves the pharmaceutical and healthcare industries, operating within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Drug Delivery.

Company Intelligence Q&A

When was Pharmmies founded?

Pharmmies was founded in January 2023.

Who is the founder of Pharmmies?

Roy Birman is the Founder & CEO of Pharmmies.

What is Pharmmies' primary product focus?

Pharmmies focuses on developing pharmaceutical gummies infused with precise dosages of Active Pharmaceutical Ingredients, including products like Clariva™, IBUMMIES™, ACETAMMIES™, AllerGum™, and Tivaro ™.

In which sector does Pharmmies primarily operate?

Pharmmies operates primarily in the Health Tech & Life Sciences sector, with a specific focus on Pharma & Medical Biotechnology and Drug Delivery.

What is the current product development stage for Pharmmies?

Pharmmies is currently in the Research & Development (R&D) stage for its pharmaceutical gummy products.